Investors Buy Shares of Monsanto Co. (MON) on Weakness Following Insider Selling
Investors bought shares of Monsanto Co. (NYSE:MON) on weakness during trading on Friday after an insider sold shares in the company. $135.47 million flowed into the stock on the tick-up and $53.93 million flowed out of the stock on the tick-down, for a money net flow of $81.54 million into the stock. Of all stocks tracked, Monsanto had the highest net in-flow for the day. Monsanto traded down ($0.43) for the day and closed at $102.11Specifically, EVP Robert T. Fraley sold 80,631 shares of the firm’s stock in a transaction that occurred on Friday, October 14th. The shares were sold at an average price of $102.04, for a total transaction of $8,227,587.24. Following the completion of the transaction, the executive vice president now owns 38,711 shares in the company, valued at approximately $3,950,070.44. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Charles S. Mcmillan purchased 3,500 shares of the stock in a transaction on Monday, October 10th. The shares were purchased at an average price of $103.23 per share, with a total value of $361,305.00. Following the acquisition, the director now owns 64,009 shares in the company, valued at approximately $6,607,649.07. The disclosure for this purchase can be found here. 0.88% of the stock is currently owned by corporate insiders.
Several research firms have issued reports on MON. S&P Equity Research restated a “positive” rating on shares of Monsanto in a report on Thursday, September 15th. JPMorgan Chase & Co. restated a “hold” rating on shares of Monsanto in a report on Thursday, June 30th. Monness Crespi & Hardt lowered their price target on shares of Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a report on Monday, October 3rd. Zacks Investment Research lowered shares of Monsanto from a “hold” rating to a “sell” rating in a report on Friday, July 1st. Finally, Vetr upgraded shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price target for the company in a report on Wednesday, August 3rd. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $114.65.
The stock has a market cap of $44.69 billion, a price-to-earnings ratio of 34.17 and a beta of 1.19. The stock’s 50 day moving average price is $104.39 and its 200 day moving average price is $101.78.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company had revenue of $2.56 billion for the quarter, compared to the consensus estimate of $2.38 billion. During the same quarter in the prior year, the company earned ($0.19) earnings per share. Monsanto’s revenue was up 8.8% on a year-over-year basis. On average, equities analysts anticipate that Monsanto Co. will post $4.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 2.12%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is 71.05%.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. WFG Advisors LP increased its position in Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares during the period. Signaturefd LLC increased its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC increased its position in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC increased its position in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the period. Finally, Carnick & Kubik LLC bought a new position in Monsanto during the first quarter valued at approximately $130,000. 79.02% of the stock is currently owned by institutional investors.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.